FNRS, Belgium Report issue

Foundation

Organization Overview

First Clinical Trial
2002
NCT00306046
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2002

Timeline

NOW
  • Now

Alternative names

FNRS (Belgium)

Active Ingredients

Drugs in Other Trials (1)

risedronate (actonel) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 1
  • # of Trial APIs: 1